14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.894 45 days ( -33.19 % )
Last Price $15.37 3.85 %
High/ Low $14.42 - $15.40 0.728%
Chg 7 Days -0.0650 % $15.38 $15.37
Chg 30 Days 12.93 % $13.61 $15.37
Chg 12 mos 34.12 % $11.46 $15.37
Trend - 3 mos 38.85 % Width: 17.02 %
Trend - 12 mos 18.57 % Width: 59.73 %
Pred. range - 3 mos $19.79 - $23.16 28.74 % - 50.65 %
Pred. range - 12 mos $11.62 - $18.56 -24.39 % - 20.78 %
Short MA avg 3 mos Buy May 15, 2024 - 4 days
Long MA avg 3 mos Buy Mar 13, 2024 - 46 days
Short/Long MA avg 3 mos Buy Mar 15, 2024 - 44 days
Short MA avg 12 mos Sell May 16, 2024 - 3 days
Long MA avg 12 mos Buy Jan 10, 2024 - 90 days
Short/Long MA avg 12 mos Buy Jan 22, 2024 - 82 days
Pivot Short Sell Apr 03, 2024 - 33 days
Bollinger Buy Apr 24, 2024 - 18 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company focuses on developing diagnostic and therapeutic products using MTR. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX66-CDx to treat bone marrow conditi... TLX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT